Lupus Anticoagulant

Causes

• Autoimmune Response:
  • The immune system produces LA, along with other antiphospholipid antibodies like anti-cardiolipin antibodies and anti-beta2-glycoprotein I antibodies.
  • These antibodies interact with proteins (like beta2-glycoprotein I) that bind to phospholipids on cell surfaces, particularly those involved in regulating blood clotting. This interaction leads to a pro-thrombotic (clot-forming) state in the body.
• Association with Autoimmune Diseases:
  • LA is most strongly associated with **Systemic Lupus Erythematosus (SLE)**, occurring in about 30-40% of SLE patients.
  • It can also be found in other autoimmune conditions such as Sjögren's syndrome, rheumatoid arthritis, or scleroderma.
• Infections:
  • Some acute viral (e.g., HIV, Hepatitis C, parvovirus, Epstein-Barr virus) or bacterial infections (e.g., syphilis) can temporarily induce the production of lupus anticoagulant. These are usually transient and do not typically lead to clinical clotting events.
• Medications:
  • Certain drugs (e.g., phenothiazines, quinidine, procainamide, hydralazine, some antibiotics) can temporarily cause the presence of lupus anticoagulant.
• Cancer: Rarely, certain cancers can be associated with the development of lupus anticoagulant.
• Genetics: While not directly inherited, there may be a genetic predisposition to developing autoimmune responses that produce these antibodies.

Symptoms

• Blood Clots (Thrombosis):
  • Deep Vein Thrombosis (DVT): Blood clots in deep veins, most commonly in the legs (pain, swelling, redness, warmth).
  • Pulmonary Embolism (PE): A blood clot that travels from a DVT to the lungs, causing sudden shortness of breath, chest pain, rapid heart rate. (Life-threatening).
  • Stroke: Blood clots in arteries leading to the brain, causing sudden numbness/weakness on one side of the body, speech difficulty, confusion, or vision problems.
  • Transient Ischemic Attack (TIA - "Mini-stroke"): Temporary stroke-like symptoms.
  • Heart Attack: Blood clots blocking coronary arteries.
  • Clots in Other Organs: Can affect kidneys, liver, eyes, etc., leading to organ dysfunction.
• Pregnancy Complications:
  • Recurrent Miscarriages: Especially in the second and third trimesters, often due to clots in the placenta.
  • Stillbirth.
  • Premature Birth.
  • Severe Preeclampsia/Eclampsia: High blood pressure and organ damage during pregnancy.
  • Placental Insufficiency: Poor blood flow to the fetus.
• Other Less Common Manifestations (Associated with Antiphospholipid Syndrome):
  • Thrombocytopenia (low platelet count - paradoxical given clotting tendency).
  • Livedo Reticularis (a purplish, lace-like mottled rash on the skin).
  • Heart valve disease.
  • Neurological symptoms like headaches, migraines, or cognitive dysfunction.

Diagnosis

• Blood Clotting Tests (Screening Tests):
  • Lupus anticoagulant interferes with certain phospholipid-dependent clotting tests in the lab. These tests will show a prolonged clotting time.
  • Activated Partial Thromboplastin Time (aPTT): Often prolonged.
  • Dilute Russell Viper Venom Time (dRVVT): Considered more specific for LA.
  • Kaolin Clotting Time (KCT).
• Mixing Studies:
  • If a screening test is prolonged, a mixing study is performed. Patient's plasma is mixed with normal pooled plasma.
  • If the prolonged clotting time *does not correct* with the addition of normal plasma, it suggests the presence of an inhibitor (like LA) rather than a clotting factor deficiency.
• Confirmatory Tests (Phospholipid-dependent tests):
  • These tests use a high concentration of phospholipids to confirm that the observed inhibition is phospholipid-dependent.
• Persistence of Antibodies:
  • A positive test for lupus anticoagulant must be confirmed with a repeat test at least 12 weeks later. This is crucial to rule out transient LA due to acute infection or medication.
• Clinical Context: The laboratory finding of LA is interpreted in the context of the patient's clinical history (e.g., recurrent blood clots, unexplained miscarriages). LA alone, without clinical events, may not warrant treatment.

Treatment

• For Patients with a History of Blood Clots:
  • Anticoagulant Medications (Blood Thinners):
    • Warfarin (Coumadin): The standard treatment. It requires careful monitoring of INR (International Normalized Ratio) to ensure the blood is thinned to a specific therapeutic range (often higher than for other clotting disorders).
    • Direct Oral Anticoagulants (DOACs): (e.g., rivaroxaban, apixaban, dabigatran, edoxaban) While commonly used for other clotting disorders, their efficacy specifically in LA-positive patients with arterial clots or recurrent venous clots is still under active investigation and often warfarin is preferred for these high-risk scenarios.
  • Lifelong anticoagulation is often recommended after a first thrombotic event.
• For Pregnant Women with Lupus Anticoagulant (to prevent complications):
  • Low-Dose Aspirin: Often started early in pregnancy.
  • Heparin (Unfractionated Heparin or Low Molecular Weight Heparin - LMWH) Injections: Started early in pregnancy and continued throughout pregnancy and often for several weeks postpartum. Heparin does not cross the placenta and is considered safe for the fetus.
  • Oral anticoagulants like warfarin are typically avoided during pregnancy due to risks to the fetus.
• For Asymptomatic Individuals with Lupus Anticoagulant:
  • Treatment may or may not be initiated. The decision depends on the specific antibody profile (e.g., persistently strong positive LA), presence of other risk factors for clotting (e.g., obesity, smoking, immobility), and family history.
  • Low-dose aspirin might be considered for primary prevention in select high-risk cases.
  • Strict avoidance of other clotting risk factors is crucial.
• Lifestyle Modifications:
  • Quit smoking.
  • Maintain a healthy weight.
  • Regular physical activity (as advised by a doctor).
  • Avoid prolonged immobility (e.g., during long flights or bed rest), consider prophylactic anticoagulation if necessary.
  • Manage underlying autoimmune conditions like SLE.

Living With a Positive Lupus Anticoagulant

A positive lupus anticoagulant is easy to over-treat and easy to under-treat. The difference comes down to whether the result was confirmed, which blood thinner is chosen, and which everyday risks are removed.

Confirming the result before acting on it

The test is unreliable while you are on a blood thinner: heparin and the direct oral anticoagulants can produce a false positive, and warfarin can distort it too, so the draw is timed around treatment and a single positive is never a diagnosis. When lupus anticoagulant is found together with anticardiolipin and anti-beta2-glycoprotein I antibodies, the triple-positive pattern, the clotting risk is considerably higher and treatment decisions become firmer. The anti-cardiolipin syndrome (APS) page covers the full syndrome, and the hypercoagulation states page covers the other clotting disorders.

Warfarin rather than a newer anticoagulant

For people who have had a clot, warfarin remains the treatment of choice. Trials comparing direct oral anticoagulants such as rivaroxaban against warfarin in antiphospholipid syndrome found more arterial clots, including strokes, on the newer drugs, particularly in triple-positive patients, so they are generally avoided. One catch is that lupus anticoagulant can interfere with the INR test used to monitor warfarin; when results seem inconsistent, a chromogenic factor X assay is used instead. During pregnancy, or as a bridge around surgery, injectable enoxaparin takes warfarin's place.

Removing the risks you control

Estrogen-containing contraception and menopausal hormone therapy are avoided because they add clot risk to clot risk; a progestin-only method or a nonhormonal approach is used instead. Smoking has the same effect, and treating nicotine dependence is part of the plan. Long car or plane trips call for movement every hour, hydration, and for some people a preventive heparin injection; our snowbird travel and blood clots article covers the details.

The company it keeps

When lupus anticoagulant accompanies systemic lupus erythematosus, hydroxychloroquine appears to lower the clotting risk as well as treating the lupus. A low platelet count, thrombocytopenia, is common and neither protects against clots nor rules out anticoagulation.

Signs that cannot wait

A swollen, painful calf, sudden breathlessness or chest pain, or any stroke symptom such as one-sided weakness or slurred speech needs emergency care, not a call the next morning; the deep venous thrombophlebitis, pulmonary embolism, and stroke pages describe what to expect. Our hematology team coordinates anticoagulation with rheumatology and obstetrics as needed. The NHLBI and MedlinePlus publish patient guidance on antiphospholipid syndrome.

If your lupus anticoagulant came back positive and you are unsure whether it was confirmed or what it means for your medications, schedule a visit.